Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
In: Feingold KR, Anawalt B, Blackman MR et al (eds) Endotext [Internet]
By simultaneously activating the GLP-1 and GIP (glucose-dependent insulinotropic peptide) receptors, tirzepatide helps promote satiety, reduce food intake, and improve glycemic control, making it an effective option for individuals struggling with obesity and related metabolic disorders
T., Morris, J
JW Pharmaceutical announced Wednesday that it has signed a license-in agreement with Chinese pharmaceutical company Gan & Lee Pharmaceuticals for the metabolic disease treatment "Bofanglutide (GZR18)." Through this agreement, JW Pharmaceutical has secured exclusive rights for domestic commercialization of the drug
US$ 27.11
US$ 20.66
US$ 23.74
US$ 25.94
US$ 26.43
US$ 29.48
US$ 21.25
US$ 25.29
